{
  "nct_id": "NCT01104415",
  "study_title": "Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome",
  "search_date": "2025-07-15T14:04:04.083255",
  "publications_found": 1,
  "publications": [
    {
      "pmid": "25636046",
      "title": "Pavel M, Horsch D, Caplin M, Ramage J, Seufferlein T, Valle J, Banks P, Lapuerta P, Sands A, Zambrow...",
      "authors": [],
      "journal": "From Clinical Trial Data",
      "year": "N/A",
      "doi": null,
      "abstract": "Pavel M, Horsch D, Caplin M, Ramage J, Seufferlein T, Valle J, Banks P, Lapuerta P, Sands A, Zambrowicz B, Fleming D, Wiedenmann B. Telotristat etiprate for carcinoid syndrome: a single-arm, multicenter trial. J Clin Endocrinol Metab. 2015 Apr;100(4):1511-9. doi: 10.1210/jc.2014-2247. Epub 2015 Jan 30.",
      "url": "https://pubmed.ncbi.nlm.nih.gov/25636046/",
      "source": "study_data"
    }
  ]
}